To verify whether MLL-r AML cells are sensitive to DNA replication inhibitors, HU was used to treat MLL germline, U937 and SKM1, and MLL-AF9, THP1 and NOMO1, cell lines for 72 h. The gene discussed is KMT2A; the disease is acute myeloid leukemia.